Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19

Xueting Li; Ying Liu; Juanjuan Song; Jiuchang Zhong

doi:10.1016/j.apsb.2020.09.003

Xueting Li, Ying Liu, Juanjuan Song, Jiuchang Zhong. Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19J. Acta Pharmaceutica Sinica B, 2020, 10(10): 2010-2014. DOI: 10.1016/j.apsb.2020.09.003

Citation:

Xueting Li, Ying Liu, Juanjuan Song, Jiuchang Zhong. Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19J. Acta Pharmaceutica Sinica B, 2020, 10(10): 2010-2014. DOI: 10.1016/j.apsb.2020.09.003

Citation:

Xueting Li, Ying Liu, Juanjuan Song, Jiuchang Zhong. Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19J. Acta Pharmaceutica Sinica B, 2020, 10(10): 2010-2014. DOI: 10.1016/j.apsb.2020.09.003

Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19

Abstract

FullText(HTML)

References (1)

Relative Articles

Supplements (1)

Cited By

/

DownLoad: Full-Size Img PowerPoint

Return

Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19

Catalog

Export File

Citation

Format

Content